Back

Rilonacept reduces pericarditis recurrence risk: clinical outcomes from the RESONANCE patient registry

31 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Pericarditis Pericarditis ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Paul Cremer

Northwestern University, Chicago (United States of America)

7 More presentations in this session

Presentation thumbnail
Pushing boundaries, not the heart: a comparative look at pericarditis recurrence in athletes
Doctor E. Angelu (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Unveiling hidden myocardial dysfunction in acute pericarditis: the prognostic power of GLS
Doctor A. Andreis (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Rilonacept as monotherapy for long-term recurrent pericarditis management: sustained disease control over three years
Doctor D. Lotan (New York, US)
Abstract Slides Video
Presentation thumbnail
Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: a case series
Doctor F. Moda (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Recurrent pericarditis: is Anakinra the only solution? Diagnostic and therapeutical insights from long-term follow-up of a large monocentric cohort
Doctor A. Giordani (Padova, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Pericarditis

The Event

Event poster

ESC Congress 2025

31 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Rilonacept as monotherapy for long-term recurrent pericarditis management: sustained disease control over three years
thumbnail
Congress Presentation
Real-life experience with rilonacept for the treatment of recurrent pericarditis
thumbnail
Congress Presentation
Increased adoption of IL-1 pathway inhibition and the steroid-sparing paradigm shift: temporal trends in recurrent pericarditis treatment from the RESONANCE patient registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources